Bill > SB3146

This bill, the 340B Drug Pricing Program Reporting Act, mandates that entities participating in the federal 340B Program, which provides discounted prescription drugs to certain healthcare organizations serving vulnerable populations, must report detailed financial and operational data to the Illinois Department of Public Health annually. Specifically, by April 1st each year starting in 2027, these "340B covered entities" (defined as eligible organizations with a service address in Illinois, including their associated sites) must submit information on their drug acquisition costs, patient payments, payments to contract pharmacies (pharmacies that dispense 340B drugs on behalf of a covered entity), how savings are used for charity care or community benefits, and overall operating and charity care costs. The Department will then compile this data into a public report by November 15th each year, which will be submitted to the General Assembly and posted online. The bill also allows pharmaceutical manufacturers to request specific dispensing information from 340B covered entities to verify proper use of 340B drugs and prevent issues like duplicate discounts or diversion, and sets penalties for non-compliance with reporting requirements. This Act is set to expire on January 1, 2031.

Government Affairs

https://www.ilga.gov/Legislation/BillStatus?DocNum=3146&GAID=18&DocTypeID=SB&SessionID=114&GA=104